StockData

GSK vs Merck

GSK and MRK side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How GSK and MRK compare

Merck grew revenue faster over the last twelve months (4.6% versus 4.1% for GSK).

GSK keeps more of each dollar of sales as profit, with a net margin of 17.5% compared with 4.8% at Merck.

Merck pays a dividend yielding 2.4%; GSK does not pay one.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricGSKMRK
Size and price
Market cap–$356B
Share price$49.24$144.46
Change, 1 year4.4%55.5%
Change, 5 years−2.1%82.5%
Beta (5Y)0.13−0.14
Employees500K75K
StockData Score
Total score99
Valuation score00
Growth score2 (better)0
Performance score4 (better)3
Health score33
Dividend score03 (better)
Valuation
P/E–116×
P/S–5.4×
P/B–8.5×
P/FCF–22.2×
PEG–13.70
FCF yield–4.5%
Fair value–$42.50
Margin of safety–−240%
Growth
Revenue growth (TTM)4.1%4.6% (better)
Revenue growth, 5Y average6.0%9.4% (better)
Net income growth (TTM)122% (better)−80.7%
EPS growth (TTM)123% (better)−80.7%
EPS growth, 5Y average−0.54%21.2% (better)
Profitability
Gross margin72.4%73.0% (better)
Operating margin24.3%–
Net margin17.5% (better)4.8%
FCF margin19.6%24.1% (better)
Return on equity38.0% (better)7.0%
Return on invested capital23.4%–
Financial health
Debt / equity1.08 (better)1.29
Net debt / EBITDA1.40–
Interest coverage11.3×–
Current ratio0.821.32 (better)
Altman Z-score–3.71
Piotroski F-score9 (better)4
Dividends and buybacks
Dividend yield–2.4%
Payout ratio44.9%262%
Years of dividend growth–15
Dividend growth, 5Y average–5.8%
Buyback yield–1.2%
Shareholder yield–3.5%
Ownership
Held by institutions8.0%80.3%
Held by insiders0.00%0.05%
Insider net buying, 12 months–−$79.3M
Superinvestors holding14 (better)
Short interest, % of float–1.1%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.